Skip to content

Comparative study on the clinical efficacy of modified ChuangMianLing dosage form and original ChuangMianLing aqueous agent in the treatment of infected wounds

Comparative study on the clinical efficacy of modified ChuangMianLing dosage form and original ChuangMianLing aqueous agent in the treatment of infected wounds

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001158
Enrollment
Unknown
Registered
2025-06-12
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infective wound

Interventions

control group:Original ChuangMianLing aqueous
test group:Mdified ChuangMianLing hydrogel

Sponsors

Dongguan Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the above diagnostic criteria for infected wounds; 2. Those aged 40 to 60 years old; 3. Patients who voluntarily undergo the test and sign the informed consent and can cooperate with the treatment; 4. Complete medical records completion of all treatment courses and follow-up visits.

Exclusion criteria

Exclusion criteria: 1. Diabetics who fail to control their blood sugar; 2. Those with poor nutritional status combined with hypoproteinaemia or vitamin deficiency; 3. Patients with previous history of anaemia; 4. Patients with BMI = 28; 5. Affected limbs with thromboembolic vasculitis and varicose veins of the lower limbs; 6. Patients with serious internal diseases (e.g. malignant tumour liver cirrhosis renal insufficiency cardiac insufficiency etc.); 7. Pregnant women; 8. Wound area 15cm²; wound width >3cm; wound depth >1cm.

Design outcomes

Primary

MeasureTime frame
Histopathological scoring of wound healing;Total length of stay;Healing time;Weekly healing rate;

Secondary

MeasureTime frame
biochemical;cholesterol;pulse;liver function;kidney function;Shedding rate of adverse events;Incidence of adverse events;pulse rate;respiratory;(body) temperature;

Countries

China

Contacts

Public ContactLao Aotian

Guangzhou University of Chinese Medicine

laoaotian@outlook.com+86 136 8611 8169

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026